Antimalarial drug
Showing 1 - 25 of >10,000
Plasmodium Falciparum Antimalarial Drug Resistance Markers
Completed
- Plasmodium Falciparum
-
Kome, Doba, ChadStudy clinic
Mar 29, 2022
Monitoring Pregnant Women for Antimalarial Drug Resistance
Recruiting
- Malaria
- Malaria screening
-
Kinsasa, Congo, The Democratic Republic of theKinshasa Medical Oxford Research Unit
Nov 25, 2021
Uncomplicated Plasmodium Falciparum Trial in Tambolaka (Dihydroartemisinin, Piperaquine, Primaquine)
Completed
- Uncomplicated Plasmodium Falciparum
- Dihydroartemisinin
- +3 more
-
Tambolaka, East Nusa Tenggara, IndonesiaKori Puskesmas
Apr 27, 2023
Malaria Genetic Surveillance
Recruiting
- Plasmodium Falciparum and Plasmodium Vivax
-
Phnom Penh, Cambodia
- +2 more
Mar 22, 2022
Covid19 Trial in Conakry (Hydroxycloroquine and Azythromycine, Cospherunate/Azythromycine,
Unknown status
- Covid19
- Hydroxycloroquine and Azythromycine
- +2 more
-
Conakry, GuineaDonka; Kenien; Gbessia
Aug 5, 2020
TES of Artemether-lumefantrine for Pf in Philippines in
Completed
- Malaria,Falciparum
- Malaria Recrudescence
- (no location specified)
Jul 20, 2023
Uncomplicated Plasmodium Falciparum Malaria Trial (Artemether-Lumefantrine-Amodiaquine (ALAQ), Artemether-Lumefantrine (AL),
Not yet recruiting
- Uncomplicated Plasmodium Falciparum Malaria
- Artemether-Lumefantrine-Amodiaquine (ALAQ)
- +2 more
- (no location specified)
Jul 20, 2023
Malaria, Malaria,Falciparum Trial in Ouagadougou (Seasonal Malaria Chemoprophylaxis (under 5 year old) implemented by the MoH
Not yet recruiting
- Malaria
- Malaria,Falciparum
- Seasonal Malaria Chemoprophylaxis (under 5 year old) implemented by the MoH without DOT
- +2 more
-
Ouagadougou, Burkina FasoGroupe de Recherche Action en Santé
May 18, 2023
Polycystic Ovary Syndrome Trial in Shanghai (Dihydroartemisinin)
Active, not recruiting
- Polycystic Ovary Syndrome
-
Shanghai, ChinaZhongshan Hospital Fudan University
Jul 15, 2022
Efficacy, Malaria, Chloroquine Trial in Arba Minch (Chloroquine, Primaquine)
Completed
- Efficacy
- +3 more
-
Arba Minch, South Ethiopia, EthiopiaShecha Health Center
Sep 19, 2023
l Antimalarial Drugs, Malaria Vaccines, and Controlled Human
Recruiting
- Malaria
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Malaria Trial in Nanoro (Sulfadoxine pyrimethamine, Amodiaquine)
Recruiting
- Malaria
- Sulfadoxine pyrimethamine
- Amodiaquine
-
Nanoro, Burkina FasoUnité de Recherche Clinique de Nanoro
Jul 26, 2022
Uncomplicated Plasmodium Falciparum Malaria Trial in Congo, The Democratic Republic of the (Artesunate-amodiaquine,
Recruiting
- Uncomplicated Plasmodium Falciparum Malaria
-
Kapolowe, Haut-Katanga, Congo, The Democratic Republic of the
- +7 more
Oct 7, 2023
Severe Malarial Treatment Trial in Lambaréné (artesunate-pyronaridine)
Not yet recruiting
- Severe Malarial Treatment
-
Lambaréné, Moyen- Ogooué, GabonCentre de Recherches Médicales de Lammbaréné
Jun 26, 2023
Plasmodium Falciparum Trial in Kilifi (Arterolane-piperaquine, Arterolane-piperaquine+mefloquine, Artemether-lumefantrine)
Completed
- Plasmodium Falciparum
- Arterolane-piperaquine
- +2 more
-
Kilifi, KenyaKilifi County Hospital
Sep 28, 2021
Malaria Trial in Kwara (Standard age based SPAQ administration for SMC)
Recruiting
- Malaria
- Standard age based SPAQ administration for SMC
-
Kwara, NigeriaKwara Sentinell Site
Jul 31, 2023
Pulmonary Sarcoidosis Trial (Hydroxychloroquine + low-dose prednisone, Prednisone)
Not yet recruiting
- Pulmonary Sarcoidosis
- Hydroxychloroquine + low-dose prednisone
- Prednisone
- (no location specified)
Feb 9, 2022
Lupus Erythematosus, Cutaneous, Subacute, Chronic Cutaneous Lupus Erythematosus Trial (BIIB059 (litifilimab))
Not yet recruiting
- Lupus Erythematosus, Cutaneous, Subacute
- Chronic Cutaneous Lupus Erythematosus
- BIIB059 (litifilimab)
- (no location specified)
Sep 12, 2023
Malaria Trial in Aweil (Sulfadoxine pyrimethamine, Amodiaquine)
Not yet recruiting
- Malaria
- Sulfadoxine pyrimethamine
- Amodiaquine
-
Aweil, Northern Bahr El Gazal, South SudanAweil South
Jul 21, 2022
Malaria, Malaria, Vivax, Plasmodium Vivax Malaria Trial in Mae Sot (Dihydroartemisinin-piperaquine plus tafenoquine (450 mg
Not yet recruiting
- Malaria
- +2 more
- Dihydroartemisinin-piperaquine plus tafenoquine (450 mg adult dose)
- Chloroquine plus Tafenoquine (450 mg adult dose)
-
Mae Sot, Tak, ThailandShoklo Malaria Research Unit (SMRU)
Mar 15, 2023
Malaria Trial in Ouagadougou (Sulphadoxine-Pyrimethamine/Amodiaquine, Dihydroartemisinin/Piperaquine (DP) plus Ivermectin (IVM))
Not yet recruiting
- Malaria
- Sulphadoxine-Pyrimethamine/Amodiaquine
- Dihydroartemisinin/Piperaquine (DP) plus Ivermectin (IVM)
-
Ouagadougou, Burkina FasoMalaria Consortium
Jul 7, 2023
Malaria,Falciparum, Parasitemia, Protozoan Infections Trial in Antwerpen (Artemether-Lumefantrine 20 Mg-120 Mg Oral Tablet,
Completed
- Malaria,Falciparum
- +3 more
- Artemether-Lumefantrine 20 Mg-120 Mg Oral Tablet
- PfSPZ-DVI Challenge
-
Antwerpen, BelgiumSGS Belgium NV Clinical Pharmacology Unit
Sep 3, 2021